help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shultz, L. D.
Right arrow Articles by Sidman, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shultz, L. D.
Right arrow Articles by Sidman, C. L.

American Journal of Pathology, Vol 116, 179-192, Copyright © 1984 by American Society for Investigative Pathology


REGULAR ARTICLES

"Viable motheaten," a new allele at the motheaten locus. I. Pathology

LD Shultz, DR Coman, CL Bailey, WG Beamer and CL Sidman

A new spontaneous autosomal recessive mutation has recently occurred at the motheaten (me) locus on Chromosome 6 in strain C57BL/6J mice. Homozygotes for the new allele, designated "viable motheaten" (mev), have a mean life span of 61 +/- 2.4 days, compared with only 22 +/- 1.3 days for C57BL/6J-me/me mice. Like the original motheaten mutation, the immediate cause of death in mev/mev mice appears to be severe pneumonitis associated with accumulations of macrophages, granulocytes, and lymphocytes in the lungs. However, because of its longer life span, progression of the disease in mev/mev mice is more amenable to investigation. Eosinophilic crystalline material in alveolar macrophages from mev/mev mice is associated with extravasation of erythrocytes into alveoli. These crystals are morphologically indistinguishable from hematoidin, which results from hemoglobin breakdown following uptake of erythrocytes by macrophages. Severe macrocytic hypochromic anemia with abnormalities in size and shape of erythrocytes develops by 7 weeks. A two-fold increase in peripheral leukocyte count and a five-fold increase in the percentage of neutrophils is seen by 10 weeks. Viable motheaten mice develop focal granulocytic skin lesions by 4 days of age, show depletion of cells from the thymus cortex by 4 weeks, and lack lymphoid follicles in the lymph nodes, spleen, and Peyer's patches. Excessive erythropoiesis and myelopoiesis in the spleen result in marked splenomegaly. Lymph nodes and spleens from mev/mev mice contain increased numbers of plasma cells by 3 weeks; and by 6 weeks, large numbers of atypical plasma cells with Russell bodies are evident. Development of glomerulonephritis by 10 weeks is characterized by granular depositis of immunoglobulin and complement within glomeruli. A twofold increase of blood urea nitrogen levels is present by 15 weeks. Sterility of male mev/mev mice is associated with Leydig cell depletion in the testes, lowered testosterone levels, and impaired spermatogenesis.


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
C. Zhu, S. Lindsey, I. Konieczna, and E. A. Eklund
Constitutive activation of SHP2 protein tyrosine phosphatase inhibits ICSBP-induced transcription of the gene encoding gp91PHOX during myeloid differentiation
J. Leukoc. Biol., March 1, 2008; 83(3): 680 - 691.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
M. J. Hoenerhoff, M. F. Starost, and J. M. Ward
Eosinophilic Crystalline Pneumonia as a Major Cause of Death in 129S4/SvJae Mice.
Vet. Pathol., September 1, 2006; 43(5): 682 - 688.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. D. Simoncic, A. Bourdeau, A. Lee-Loy, L. R. Rohrschneider, M. L. Tremblay, E. R. Stanley, and C. J. McGlade
T-cell protein tyrosine phosphatase (tcptp) is a negative regulator of colony-stimulating factor 1 signaling and macrophage differentiation.
Mol. Cell. Biol., June 1, 2006; 26(11): 4149 - 4160.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
R. L Cassady-Cain and A. K Kaushik
Increased negative selection impairs neonatal B cell repertoire but does not directly lead to generation of disease-associated IgM auto-antibodies
Int. Immunol., May 1, 2006; 18(5): 661 - 669.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
B. L. Lyons, R. S. Smith, R. E. Hurd, N. L. Hawes, L. M. Burzenski, S. Nusinowitz, M. G. Hasham, B. Chang, and L. D. Shultz
Deficiency of SHP-1 Protein-Tyrosine Phosphatase in "Viable Motheaten" Mice Results in Retinal Degeneration.
Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1201 - 1209.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Nishimura and J. L. Strominger
Involvement of a tissue-specific autoantibody in skin disorders of murine systemic lupus erythematosus and autoinflammatory diseases
PNAS, February 28, 2006; 103(9): 3292 - 3297.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Fan, M. Zhou, M. K. Pathak, D. J. Lindner, C. Z. Altuntas, V. K. Tuohy, E. C. Borden, and T. Yi
Sodium Stibogluconate Interacts with IL-2 in Anti-Renca Tumor Action via a T Cell-Dependent Mechanism in Connection with Induction of Tumor-Infiltrating Macrophages
J. Immunol., November 15, 2005; 175(10): 7003 - 7008.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. R. D. Paling and M. J. Welham
Tyrosine phosphatase SHP-1 acts at different stages of development to regulate hematopoiesis
Blood, June 1, 2005; 105(11): 4290 - 4297.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. W. Harder, C. Quilici, E. Naik, M. Inglese, N. Kountouri, A. Turner, K. Zlatic, D. M. Tarlinton, and M. L. Hibbs
Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1
Blood, December 15, 2004; 104(13): 3901 - 3910.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Wei, J. Guo, A. I. Doseff, D. F. Kusewitt, A. K. Man, R. G. Oshima, and M. C. Ostrowski
Activated Ets2 Is Required for Persistent Inflammatory Responses in the Motheaten Viable Model
J. Immunol., July 15, 2004; 173(2): 1374 - 1379.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. Ernst, M. Inglese, G. M. Scholz, K. W. Harder, F. J. Clay, S. Bozinovski, P. Waring, R. Darwiche, T. Kay, P. Sly, et al.
Constitutive Activation of the Src Family Kinase Hck Results in Spontaneous Pulmonary Inflammation and an Enhanced Innate Immune Response
J. Exp. Med., September 2, 2002; 196(5): 589 - 604.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Deng, A. Minguela, R. Z. Hussain, A. E. Lovett-Racke, C. Radu, E. S. Ward, and M. K. Racke
Expression of the Tyrosine Phosphatase Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase 1 Determines T Cell Activation Threshold and Severity of Experimental Autoimmune Encephalomyelitis
J. Immunol., May 1, 2002; 168(9): 4511 - 4518.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
P.-A. Oldenborg, H. D. Gresham, and F. P. Lindberg
CD47-Signal Regulatory Protein {{alpha}} (SIRP{{alpha}}) Regulates Fc{{gamma}} and Complement Receptor-mediated Phagocytosis
J. Exp. Med., April 2, 2001; 193(7): 855 - 862.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
H. Keilhack, M. Muller, S.-A. Bohmer, C. Frank, K. M. Weidner, W. Birchmeier, T. Ligensa, A. Berndt, H. Kosmehl, B. Gunther, et al.
Negative Regulation of Ros Receptor Tyrosine Kinase Signaling: An Epithelial Function of the SH2 Domain Protein Tyrosine Phosphatase SHP-1
J. Cell Biol., January 22, 2001; 152(2): 325 - 334.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Kruger, J. R. Butler, V. Cherapanov, Q. Dong, H. Ginzberg, A. Govindarajan, S. Grinstein, K. A. Siminovitch, and G. P. Downey
Deficiency of Src Homology 2-Containing Phosphatase 1 Results in Abnormalities in Murine Neutrophil Function: Studies in Motheaten Mice
J. Immunol., November 15, 2000; 165(10): 5847 - 5859.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. L. Stoll and J. Gavalchin
Systemic lupus erythematosus--messages from experimental models
Rheumatology, January 1, 2000; 39(1): 18 - 27.
[Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. L. Russell and J. S. Richards
Differentiation-Dependent Prolactin Responsiveness and Stat (Signal Transducers and Activators of Transcription) Signaling in Rat Ovarian Cells
Mol. Endocrinol., December 1, 1999; 13(12): 2049 - 2064.
[Abstract] [Full Text]


Home page
J. Exp. Med.Home page
C. H. Kim, C.-K. Qu, G. Hangoc, S. Cooper, N. Anzai, G.-S. Feng, and H. E. Broxmeyer
Abnormal Chemokine-induced Responses of Immature and Mature Hematopoietic Cells from Motheaten Mice Implicate the Protein Tyrosine Phosphatase SHP-1 in Chemokine Responses
J. Exp. Med., September 6, 1999; 190(5): 681 - 690.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Martin, H. W. Tsui, M. J. Shulman, D. Isenman, and F. W. L. Tsui
Murine SHP-1 Splice Variants with Altered Src Homology 2 (SH2) Domains. IMPLICATIONS FOR THE SH2-MEDIATED INTRAMOLECULAR REGULATION OF SHP-1
J. Biol. Chem., July 30, 1999; 274(31): 21725 - 21734.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Umeda, W. G. Beamer, K. Takagi, M. Naito, S.-I. Hayashi, H. Yonemitsu, T. Yi, and L. D. Shultz
Deficiency of SHP-1 Protein-Tyrosine Phosphatase Activity Results in Heightened Osteoclast Function and Decreased Bone Density
Am. J. Pathol., July 1, 1999; 155(1): 223 - 233.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. R. Plas, C. B. Williams, G. J. Kersh, L. S. White, J. M. White, S. Paust, T. Ulyanova, P. M. Allen, and M. L. Thomas
Cutting Edge: The Tyrosine Phosphatase SHP-1 Regulates Thymocyte Positive Selection
J. Immunol., May 15, 1999; 162(10): 5680 - 5684.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Q. Dong, K. A. Siminovitch, L. Fialkow, T. Fukushima, and G. P. Downey
Negative Regulation of Myeloid Cell Proliferation and Function by the SH2 Domain-Containing Tyrosine Phosphatase-1
J. Immunol., March 15, 1999; 162(6): 3220 - 3230.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. B. Dustin, D. R. Plas, J. Wong, Y. T. Hu, C. Soto, A. C. Chan, and M. L. Thomas
Expression of Dominant-Negative Src-Homology Domain 2-Containing Protein Tyrosine Phosphatase-1 Results in Increased Syk Tyrosine Kinase Activity and B Cell Activation
J. Immunol., March 1, 1999; 162(5): 2717 - 2724.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Dautigny, A. Le Campion, and B. Lucas
Timing and Casting for Actors of Thymic Negative Selection
J. Immunol., February 1, 1999; 162(3): 1294 - 1302.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
J. A. Frearson and D. R. Alexander
The Phosphotyrosine Phosphatase SHP-2 Participates in a Multimeric Signaling Complex and Regulates T Cell Receptor (TCR) coupling to the Ras/Mitogen-activated Protein Kinase (MAPK) Pathway in Jurkat T Cells
J. Exp. Med., May 4, 1998; 187(9): 1417 - 1426.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
D D'Ambrosio, K. Hippen, S. Minskoff, I Mellman, G Pani, K. Siminovitch, and J. Cambier
Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1
Science, April 14, 1995; 268(5208): 293 - 297.
[Abstract] [PDF]


Home page
ScienceHome page
C. Sidman, L. Shultz, R. Hardy, K Hayakawa, and L. Herzenberg
Production of immunoglobulin isotypes by Ly-1+ B cells in viable motheaten and normal mice
Science, June 13, 1986; 232(4756): 1423 - 1425.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American Society for Investigative Pathology.